Companies May See Inspection Relief Under Joint U.S., EU Initiative

The FDA and European Medicines Agency (EMA) plan to step up cooperation on manufacturing inspections next month, moving from information sharing and joint inspections to outright reliance on one another’s results.
Washington Drug Letter